Fresh Corneal Lenticule Implantation in Hyperopic Patients With High Astigmatism
NCT: NCT04616144 · ACTIVE_NOT_RECRUITING
Brief Summary
The refractive combination of high hyperopia with high astigmatism is difficult to treat surgically. In addition, there are not many suitable options to offer such patients presenting with this condition. The method used at the EYE Hospital Pristina using fresh lenticule implantation by ReLex-SMILE is safe and effective method. Fresh Corneal Implantation is a safe treatment for hyperopia with high astigmatism comparing with refractive IOL implantation (loss of accommodation, endophthalmitis). Its primary objective is to increase visual acuity, accommodation process, patient satisfaction which makes patient to enjoy a happier life. We believe this study will be the future of refractive surgery for treating high hyperopia.
Frequently Asked Questions
What is Fresh Corneal Lenticule Implantation in Hyperopic Patients With High Astigmatism?
Fresh Corneal Lenticule Implantation in Hyperopic Patients With High Astigmatism is a clinical trial registered under NCT04616144. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT04616144?
The current status of NCT04616144 (Fresh Corneal Lenticule Implantation in Hyperopic Patients With High Astigmatism) is: ACTIVE_NOT_RECRUITING.
When did Fresh Corneal Lenticule Implantation in Hyperopic Patients With High Astigmatism start?
Fresh Corneal Lenticule Implantation in Hyperopic Patients With High Astigmatism started on 2019-05-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.